Enhanced AMPAR-dependent synaptic transmission by S-nitrosylation in the vmPFC contributes to chronic inflammatory pain-induced persistent anxiety in mice

[1]  Fei Li,et al.  A pain killer without analgesic tolerance designed by co-targeting PSD-95-nNOS interaction and α2-containning GABAARs , 2021, Theranostics.

[2]  Lei Chang,et al.  Environmental enrichment implies GAT-1 as a potential therapeutic target for stroke recovery , 2021, Theranostics.

[3]  Lei Chang,et al.  Neuronal Nitric Oxide Synthase in Nucleus Accumbens Specifically Mediates Susceptibility to Social Defeat Stress through Cyclin-Dependent Kinase 5 , 2021, The Journal of Neuroscience.

[4]  Ulrich Dirnagl,et al.  The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research* , 2020, BMC Veterinary Research.

[5]  Esther J Pearl,et al.  The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research , 2020, PLoS biology.

[6]  Lei Chang,et al.  nNOS-expressing neurons in the vmPFC transform pPVT-derived chronic pain signals into anxiety behaviors , 2020, Nature Communications.

[7]  Yue Wang,et al.  Spontaneous Pain Disrupts Ventral Hippocampal CA1-Infralimbic Cortex Connectivity and Modulates Pain Progression in Rats with Peripheral Inflammation. , 2019, Cell reports.

[8]  K. Solati,et al.  Effect of progressive muscle relaxation with analgesic on anxiety status and pain in surgical patients. , 2019, British journal of nursing.

[9]  Y. Tao,et al.  Disrupting interaction of PSD-95 with nNOS attenuates hemorrhage-induced thalamic pain , 2018, Neuropharmacology.

[10]  Lei Chang,et al.  Dissociation of nNOS from PSD‐95 promotes functional recovery after cerebral ischaemia in mice through reducing excessive tonic GABA release from reactive astrocytes , 2018, The Journal of pathology.

[11]  S. Brill,et al.  Depression and anxiety among chronic pain patients receiving prescription opioids and medical marijuana. , 2017, Journal of affective disorders.

[12]  Y. Humeau,et al.  Hippocampal LTP and contextual learning require surface diffusion of AMPA receptors , 2017, Nature.

[13]  A. Velly,et al.  Epidemiology of pain and relation to psychiatric disorders , 2017, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[14]  A. Hohmann,et al.  Small molecule inhibitors of PSD95–nNOS protein–protein interactions suppress formalin-evoked Fos protein expression and nociceptive behavior in rats , 2017, Neuroscience.

[15]  N. Heintz,et al.  A Cortical Circuit for Sexually Dimorphic Oxytocin-Dependent Anxiety Behaviors , 2016, Cell.

[16]  Min Zhuo,et al.  Synaptic plasticity in the anterior cingulate cortex in acute and chronic pain , 2016, Nature Reviews Neuroscience.

[17]  Min Zhuo,et al.  Neural Mechanisms Underlying Anxiety–Chronic Pain Interactions , 2016, Trends in Neurosciences.

[18]  A. Hohmann,et al.  Small molecule inhibitors of PSD95-nNOS protein–protein interactions as novel analgesics , 2015, Neuropharmacology.

[19]  Xuemei Liu,et al.  Deactivation of excitatory neurons in the prelimbic cortex via Cdk5 promotes pain sensation and anxiety , 2015, Nature Communications.

[20]  D. Zhu,et al.  (+)-Borneol alleviates mechanical hyperalgesia in models of chronic inflammatory and neuropathic pain in mice. , 2015, European journal of pharmacology.

[21]  Ashley N. Ferreira,et al.  Highly differentiated cellular and circuit properties of infralimbic pyramidal neurons projecting to the periaqueductal gray and amygdala , 2015, Front. Cell. Neurosci..

[22]  Juan Zhang,et al.  Differential roles of hippocampal glutamatergic receptors in neuropathic anxiety-like behavior after partial sciatic nerve ligation in rats , 2015, BMC Neuroscience.

[23]  G. Collingridge,et al.  Coexistence of Two Forms of LTP in ACC Provides a Synaptic Mechanism for the Interactions between Anxiety and Chronic Pain , 2015, Neuron.

[24]  A. Beekman,et al.  The Association of Depression and Anxiety with Pain: A Study from NESDA , 2014, PloS one.

[25]  D. Baehrens,et al.  Regional Diversity and Developmental Dynamics of the AMPA-Receptor Proteome in the Mammalian Brain , 2014, Neuron.

[26]  Fengyun Zhang,et al.  Interaction of nNOS with PSD-95 Negatively Controls Regenerative Repair after Stroke , 2014, The Journal of Neuroscience.

[27]  W. Lu,et al.  CAPON-nNOS coupling can serve as a target for developing new anxiolytics , 2014, Nature Medicine.

[28]  M. Yamada,et al.  Activation of the prelimbic medial prefrontal cortex induces anxiety‐like behaviors via N‐Methyl‐D‐aspartate receptor‐mediated glutamatergic neurotransmission in mice , 2014, Journal of neuroscience research.

[29]  K. Hung,et al.  Upregulation of presynaptic proteins and protein kinases associated with enhanced glutamate release from axonal terminals (synaptosomes) of the medial prefrontal cortex in rats with neuropathic pain , 2014, PAIN®.

[30]  Shu-ji Li,et al.  Enhanced excitability in the infralimbic cortex produces anxiety-like behaviors , 2013, Neuropharmacology.

[31]  Y. Golub,et al.  Activation of GABAA receptors in the medial prefrontal cortex produces an anxiolytic-like response , 2013, Acta Neuropsychiatrica.

[32]  R. Huganir,et al.  S-nitrosylation of AMPA receptor GluA1 regulates phosphorylation, single-channel conductance, and endocytosis , 2012, Proceedings of the National Academy of Sciences.

[33]  K. Roche,et al.  Posttranslational Regulation of Ampa Receptor Trafficking and Function This Review Comes from a Themed Issue on Synaptic Structure and Function Edited , 2022 .

[34]  M. Koenigs,et al.  Functional anatomy of ventromedial prefrontal cortex: implications for mood and anxiety disorders , 2012, Molecular Psychiatry.

[35]  B. Penninx,et al.  Impact of pain on the course of depressive and anxiety disorders , 2012, PAIN.

[36]  P. Greengard,et al.  Antidepressant effects of selective serotonin reuptake inhibitors (SSRIs) are attenuated by antiinflammatory drugs in mice and humans , 2011, Proceedings of the National Academy of Sciences.

[37]  M. Wolf,et al.  Quantitative analysis of AMPA receptor subunit composition in addiction-related brain regions , 2011, Brain Research.

[38]  W. Lu,et al.  Treatment of cerebral ischemia by disrupting ischemia-induced interaction of nNOS with PSD-95 , 2010, Nature Medicine.

[39]  R. Dingledine,et al.  Glutamate Receptor Ion Channels: Structure, Regulation, and Function , 2010, Pharmacological Reviews.

[40]  R. Huganir,et al.  S-nitrosylation of stargazin regulates surface expression of AMPA-glutamate neurotransmitter receptors , 2009, Proceedings of the National Academy of Sciences.

[41]  R. Nicoll,et al.  Silent synapses and the emergence of a postsynaptic mechanism for LTP , 2008, Nature Reviews Neuroscience.

[42]  Jingwei Wu,et al.  Association of Depression and Anxiety Alone and in Combination With Chronic Musculoskeletal Pain in Primary Care Patients , 2008, Psychosomatic medicine.

[43]  Min Zhuo,et al.  Presynaptic and Postsynaptic Amplifications of Neuropathic Pain in the Anterior Cingulate Cortex , 2008, The Journal of Neuroscience.

[44]  Xiao Han,et al.  Reduced neuronal nitric oxide synthase is involved in ischemia‐induced hippocampal neurogenesis by up‐regulating inducible nitric oxide synthase expression , 2007, Journal of neurochemistry.

[45]  Dan J Stein,et al.  Mental disorders among persons with chronic back or neck pain: Results from the world mental health surveys , 2007, PAIN.

[46]  Solomon H. Snyder,et al.  S-Nitrosylation of N-Ethylmaleimide Sensitive Factor Mediates Surface Expression of AMPA Receptors , 2005, Neuron.

[47]  Gavin Rumbaugh,et al.  Phosphorylation of the AMPA Receptor GluR1 Subunit Is Required for Synaptic Plasticity and Retention of Spatial Memory , 2003, Cell.

[48]  I. Song,et al.  Regulation of AMPA receptors during synaptic plasticity , 2002, Trends in Neurosciences.

[49]  Robert J Gatchel,et al.  Chronic Pain and Psychopathology: Research Findings and Theoretical Considerations , 2002, Psychosomatic medicine.

[50]  D. Price.  Psychological and neural mechanisms of the affective dimension of pain. , 2000, Science.

[51]  K. Svoboda,et al.  Rapid spine delivery and redistribution of AMPA receptors after synaptic NMDA receptor activation. , 1999, Science.

[52]  R. Huganir,et al.  Activity-Dependent Modulation of Synaptic AMPA Receptor Accumulation , 1998, Neuron.

[53]  R. Nicoll,et al.  Activity differentially regulates the surface expression of synaptic AMPA and NMDA glutamate receptors. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[54]  R. Wenthold,et al.  Evidence for multiple AMPA receptor complexes in hippocampal CA1/CA2 neurons , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[55]  S. Snyder,et al.  Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[56]  R. Kessler,et al.  The associations between preexisting mental disorders and subsequent onset of chronic headaches: a worldwide epidemiologic perspective. , 2015, The journal of pain : official journal of the American Pain Society.